347
Views
32
CrossRef citations to date
0
Altmetric
Editorial

The future of obesity: new drugs versus lifestyle interventions

Pages 263-267 | Published online: 06 Mar 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hongyu Zhao, Michael D Serby & Bo Liu. (2008) The prospects of antagonizing the growth hormone secretagogue receptor to treat obesity. Expert Opinion on Therapeutic Patents 18:9, pages 989-998.
Read now

Articles from other publishers (31)

Marcia Lange, Devika Nadkarni, Lily Martin, Carolyn Newberry, Sonal Kumar & Tatyana Kushner. (2023) Intermittent fasting improves hepatic end points in nonalcoholic fatty liver disease: A systematic review and meta-analysis. Hepatology Communications 7:8.
Crossref
Bernd Niemann, Ruping Pan, Hassan Issa, Andreas Simm, Rainer Schulz & Susanne Rohrbach. (2022) AMPK Activation Is Indispensable for the Protective Effects of Caloric Restriction on Left Ventricular Function in Postinfarct Myocardium. Biology 11:3, pages 448.
Crossref
André J. Scheen. (2021) Médicaments anti-obésité : leçons des échecs pour l’avenir. Médecine des Maladies Métaboliques 15:8, pages 734-743.
Crossref
Antonio Munafò, Stefano Frara, Norberto Perico, Rosaria Di Mauro, Monica Cortinovis, Chiara Burgaletto, Giuseppina Cantarella, Giuseppe Remuzzi, Andrea Giustina & Renato Bernardini. (2021) In search of an ideal drug for safer treatment of obesity: The false promise of pseudoephedrine. Reviews in Endocrine and Metabolic Disorders 22:4, pages 1013-1025.
Crossref
Stephen D. Anton, Yenisel Cruz-Almeida, Arashdeep Singh, Jordan Alpert, Benjamin Bensadon, Melanie Cabrera, David J. Clark, Natalie C. Ebner, Karyn A. Esser, Roger B. Fillingim, Soamy Montesino Goicolea, Sung Min Han, Henrique Kallas, Alisa Johnson, Christiaan Leeuwenburgh, Andrew C. Liu, Todd M. Manini, Michael Marsiske, Frederick Moore, Peihua Qiu, Robert T. Mankowski, Mamoun Mardini, Christian McLaren, Sanjay Ranka, Parisa Rashidi, Sunil Saini, Kimberly T. Sibille, Shinichi Someya, Stephanie Wohlgemuth, Carolyn Tucker, Rui Xiao & Marco Pahor. (2020) Innovations in Geroscience to enhance mobility in older adults. Experimental Gerontology 142, pages 111123.
Crossref
James L. Dorling, Corby K. Martin & Leanne M. Redman. (2020) Calorie restriction for enhanced longevity: The role of novel dietary strategies in the present obesogenic environment. Ageing Research Reviews 64, pages 101038.
Crossref
Wheeler Torres, Manuel Nava, Nestor Galbán, Yosselin Gómez, Valery Morillo, Milagros Rojas, Clímaco Cano, Maricarmen Chacín, Luis D´Marco, Yaneth Herazo, Manuel Velasco, Valmore Bermúdez & Joselyn Rojas-Quintero. (2020) Anti-Aging Effect of Metformin: A Molecular and Therapeutical Perspective. Current Pharmaceutical Design 26:35, pages 4496-4508.
Crossref
Mohammad Zeinali Khosroshahi, Omid Asbaghi, Sajjad Moradi, Mahnaz Rezaei kelishadi, Mojtaba Kaviani, Mahnaz Mardani & Cyrus Jalili. (2020) The effects of supplementation with L-arginine on anthropometric indices and body composition in overweight or obese subjects: A systematic review and meta-analysis. Journal of Functional Foods 71, pages 104022.
Crossref
Yongin Cho, Namki Hong, Kyung-won Kim, Sung Cho, Minyoung Lee, Yeon-hee Lee, Yong-ho Lee, Eun Kang, Bong-Soo Cha & Byung-Wan Lee. (2019) The Effectiveness of Intermittent Fasting to Reduce Body Mass Index and Glucose Metabolism: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 8:10, pages 1645.
Crossref
Stephen D. Anton, Stephanie A. Lee, William T. Donahoo, Christian McLaren, Todd Manini, Christiaan Leeuwenburgh & Marco Pahor. (2019) The Effects of Time Restricted Feeding on Overweight, Older Adults: A Pilot Study. Nutrients 11:7, pages 1500.
Crossref
Amy T. Hutchison, Bo Liu, Rachel E. Wood, Andrew D. Vincent, Campbell H. Thompson, Nathan J. O’Callaghan, Gary A. Wittert & Leonie K. Heilbronn. (2018) Effects of Intermittent Versus Continuous Energy Intakes on Insulin Sensitivity and Metabolic Risk in Women with Overweight. Obesity 27:1, pages 50-58.
Crossref
Gabriela Y. Cortés-Moreno, José E. Roa-Coria, Ángel Zúñiga-Romero, Juan C. Huerta-Cruz, Eleazar Lara-Padilla, Cecilia F. del Valle-Laisequilla, Héctor I. Rocha-González & Juan G. Reyes-García. (2018) Anorectic efficacy and safety of the diethylpropion-topiramate combination in rats. Drug Development Research 79:5, pages 225-233.
Crossref
Stephen D. Anton, Keelin Moehl, William T. Donahoo, Krisztina Marosi, Stephanie A. Lee, Arch G. MainousIIIIII, Christiaan Leeuwenburgh & Mark P. Mattson. (2018) Flipping the Metabolic Switch: Understanding and Applying the Health Benefits of Fasting. Obesity 26:2, pages 254-268.
Crossref
Huei-Bin Wang, Dawn H. Loh, Daniel S. Whittaker, Tamara Cutler, David Howland & Christopher S. Colwell. (2018) Time-Restricted Feeding Improves Circadian Dysfunction as well as Motor Symptoms in the Q175 Mouse Model of Huntington’s Disease. eneuro 5:1, pages ENEURO.0431-17.2017.
Crossref
Laura C. D. Pomatto & Kelvin J. A. Davies. (2017) The role of declining adaptive homeostasis in ageing. The Journal of Physiology 595:24, pages 7275-7309.
Crossref
Stephen Anton, Azumi Hida, Kacey Heekin, Kristen Sowalsky, Christy Karabetian, Heather Mutchie, Christiaan Leeuwenburgh, Todd Manini & Tracey Barnett. (2017) Effects of Popular Diets without Specific Calorie Targets on Weight Loss Outcomes: Systematic Review of Findings from Clinical Trials. Nutrients 9:8, pages 822.
Crossref
M. Vallis. (2016) Quality of life and psychological well‐being in obesity management: improving the odds of success by managing distress. International Journal of Clinical Practice 70:3, pages 196-205.
Crossref
J R Aunan, M M Watson, H R Hagland & K Søreide. (2016) Molecular and biological hallmarks of ageing. British Journal of Surgery 103:2, pages e29-e46.
Crossref
Armando Cardoso, Diogo Silva, Sara Magano, Pedro A. Pereira & Jos? P. Andrade. (2014) Old-onset caloric restriction effects on neuropeptide Y- and somatostatin-containing neurons and on cholinergic varicosities in the rat hippocampal formation. AGE 36:6.
Crossref
Jens Jordan, Arne Astrup, Stefan Engeli, Krzysztof Narkiewicz, Wesley W. Day & Nick Finer. (2014) Cardiovascular effects of phentermine and topiramate. Journal of Hypertension 32:6, pages 1178-1188.
Crossref
S. D. Anton, C. Karabetian, K. Heekin & C. Leeuwenburgh. (2013) Caloric Restriction to Moderate Senescence: Mechanisms and Clinical Utility. Current Translational Geriatrics and Experimental Gerontology Reports 2:4, pages 239-246.
Crossref
Kathryn R. Middleton, Stephen D. Anton & Michal G. Perri. (2013) Long-Term Adherence to Health Behavior Change. American Journal of Lifestyle Medicine 7:6, pages 395-404.
Crossref
Stephen Anton & Christiaan Leeuwenburgh. (2013) Fasting or caloric restriction for Healthy Aging. Experimental Gerontology 48:10, pages 1003-1005.
Crossref
Anders Nedergaard, Kim Henriksen, Morten A. Karsdal & Claus Christiansen. (2013) Musculoskeletal ageing and primary prevention. Best Practice & Research Clinical Obstetrics & Gynaecology 27:5, pages 673-688.
Crossref
Stephen D. Anton, Eric LeBlanc, H. Raymond Allen, Christy Karabetian, Frank Sacks, George Bray & Donald A. Williamson. (2012) Use of a Computerized Tracking System to Monitor and Provide Feedback on Dietary Goals for Calorie-Restricted Diets: The POUNDS LOST Study. Journal of Diabetes Science and Technology 6:5, pages 1216-1225.
Crossref
A.J. Scheen. (2010) Cardiovascular Risk-Benefit Profile of Sibutramine. American Journal Cardiovascular Drugs 10:5, pages 321-334.
Crossref
J A Higgins, A L LaSalle, P Zhaoxing, M Y Kasten, K N Bing, S E Ridzon & T L Witten. (2009) Validation of photographic food records in children: are pictures really worth a thousand words?. European Journal of Clinical Nutrition 63:8, pages 1025-1033.
Crossref
N. Esser, N. Paquot & A. -J. Scheen. (2009) Sujets « métaboliquement sains », bien qu’obèses. Deuxième partie : pronostic et prise en chargeMetabolically healthy, but obese subjects. Second part: prognosis and management. Obésité 4:2, pages 134-141.
Crossref
André J. Scheen & Nicolas Paquot. (2009) Use of cannabinoid CB1 receptor antagonists for the treatment of metabolic disorders. Best Practice & Research Clinical Endocrinology & Metabolism 23:1, pages 103-116.
Crossref
E. Beck, N. Paquot & A. J. Scheen. (2008) Sujets « métaboliquement obèses » de poids normal. Seconde partie: pronostic et prise en chargeMetabolically obese normal-weight subjects. Part two: prognosis and management. Obésité 3:4, pages 280-285.
Crossref
André J. Scheen. (2008) Abdominal adiposity: Early intervention and therapeutic options. Clinical Cornerstone 9, pages S20-S27.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.